A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T. J. van Bussel, Jan H.M. Schellens, Dorte Nielsen et al.|British Journal of Cancer|2020Cited by 127
Double blind, placebo-controlled randomized study of chlorhexidine prophylaxis for chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy)Jakob B. Sørensen, Steen Ingeberg, Torben Skovsgaard et al.|Journal of Clinical Oncology|2006Cited by 4